Gifford Bioscience LIMITED
England
- UEI
- S5NXYF5SE3S1
- CAGE
- U1N81
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- SAM.gov registration date
- Physical address
- 97 Vincent Dr, Birmingham B15 2SQ, UK
- Website
- giffordbioscience.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $27,618 |
Contract awards
Similar vendors
About the company
Gifford Bioscience LIMITED is an international organization registered as a for-profit limited liability company in the U.S. federal contracting system. The company has been active in federal contracting since at least April 2020, when it first registered in SAM.gov. Gifford Bioscience LIMITED primarily provides scientific research and pharmacology services to the National Institute on Drug Abuse (NIDA), a division of the National Institutes of Health (NIH). While specific details about the company's background are not provided, its contract history suggests expertise in biomedical research, particularly in areas related to drug abuse and addiction studies.
The company has secured multiple purchase order contracts with NIDA, demonstrating a consistent relationship with this agency. In March 2024, Gifford Bioscience LIMITED was awarded a $12,655 contract to provide unspecified products or services in support of NIDA's research efforts, with work to be performed in Baltimore, Maryland. Previously, in December 2023, the company received a similar $15,000 contract from NIDA for a one-year period. Notably, in October 2020, Gifford Bioscience LIMITED was awarded a $12,820 contract specifically for pharmacology services, including radiolabeling and binding assays for COVID-19 research. This contract was designated under the National Interest Action Code for Coronavirus COVID-19, highlighting the company's ability to contribute to urgent public health research needs. All of these contracts were awarded without set-aside provisions, suggesting that Gifford Bioscience LIMITED competes successfully in open market procurements. The consistent nature of these awards indicates that the company has established itself as a reliable partner for NIDA in conducting specialized biomedical research and providing pharmacological services.
Quick answers
Is Gifford Bioscience LIMITED registered in SAM.gov?
Yes. Gifford Bioscience LIMITED's SAM.gov registration is active through December 2, 2026.
How much has Gifford Bioscience LIMITED received in federal contracts?
Federal contracts obligated $27,618 to Gifford Bioscience LIMITED in fiscal years 2023 through 2027.
What is Gifford Bioscience LIMITED's most recent federal award?
Gifford Bioscience LIMITED's most recent federal contract award is Gifford bioscience limited:1340014 [24-002110] (75N95024P00187), from National Institute on Drug Abuse (NIH), on March 13, 2024.
On GovTribe
See Gifford Bioscience LIMITED's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors